tc99m-tilmanocept (Lymphoseek) Report issue

Biologics Recombinant protein Imaging Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH

Active Ingredient History

NOW
  • Now
Technetium (99mTc) tilmanocept, trade name Lymphoseek, is a radiopharmaceutical diagnostic imaging agent approved for the imaging of lymph nodes. It is used to locate those lymph nodes which may be draining from tumors, and assist doctors in locating those lymph nodes for removal during surgery.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: No
  • Imaging: 99-technetium
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

1600 | 99mtc-dtpa-mannosyl-dextran | (99m)tc-tilmanocept | 99mtc-tilmanocept | lymphoseek | tc 99m tilmanocept | tc99m tilmanocept | tc99m-tilmanocept | tc-dtpa-mannosyl-dextran | technetium (99mtc) tilmanocept | technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran | technetium tc 99m tilmanocept | technetium tc-99m tilmanocept | tilmanocept

Organizations (14)

Research & Development (14)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (20)

Approved Indications (3)


 

Breast Neoplasms (approved 2013)

Carcinoma, Squamous Cell (approved 2013)

Melanoma (approved 2013)

Experimental Indications - Clinical Trial Phases 1-4 (19)


 

Anus Neoplasms (Phase 2)

Arthritis, Rheumatoid (Phase 3)

Breast Neoplasms (Phase 4)

Central Nervous System Neoplasms (Phase 1)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 1)

Endometrial Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 4)

HIV Infections (Early Phase 1)

Melanoma (Phase 4)

Neoplasm Metastasis (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 1)

Rectal Neoplasms (Phase 2)

Rhabdomyosarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Sentinel Lymph Node (Phase 4)

Sentinel Lymph Node Biopsy (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial Organizations: 14

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue